Two post-hoc analyses of a clinical trial found that patients with heart failure who received sacubitril/valsartan (Entresto) had lower reductions in health-related quality of life and lower risks of cardiovascular death and heart failure hospitalization.

A randomized trial found that patients had similar rates of survival and quality of life whether they underwent elective open and endovascular repair of their aortic abdominal aneurysm (AAA). The procedures also had similar costs and cost-effectiveness ratios.

A new transcatheter aortic valve implantation (TAVI) by Boston Scientific has received market approval in Europe.

Among adults with a normal thyroid function, higher free thyroxine (FT4) levels were associated with a 2.5-fold increased risk of sudden cardiac death, according to a prospective, population-based cohort study. The association was independent of cardiovascular risk factors such as high cholesterol and high blood pressure.

Women who experience menopause earlier are at greater risk for cardiovascular issues such as heart disease and stroke and even have greater all-cause mortality rates than women who experience menopause nearer the average age of 51, according to a new study published in the Journal of the American Medical Association Cardiology.

 

Current Events

 - San Juan webinar
Sponsored by Abiomed
October 13, 2016 - 2:00pm to 3:00pm
San Juan Regional Medical Center's ongoing training and protocols has served the heart team well and their advice is solid for care providers seeking to offer quality care while maintaining a healthy bottom line.